港股午评：恒指涨1.36%、科指涨1.45%，科网股、电力设备股普遍走高，消费电子及芯片股多走低

Market Performance - The Hong Kong stock market opened higher and experienced a rebound, with the Hang Seng Index rising by 1.36% to 25,878.49 points, the Hang Seng Tech Index increasing by 1.45% to 5,614.94 points, the National Enterprises Index up by 1.17% to 9,038.54 points, and the Red Chip Index gaining 0.72% to 4,132.23 points [1] Sector Performance - Major technology stocks generally rose, with Alibaba up by 1.2%, Tencent Holdings increasing by 1%, JD.com rising by 0.7%, Xiaomi up by 2.7%, NetEase increasing by 2.19%, Meituan rising by 1.97%, Kuaishou up by 1.35%, and Bilibili increasing by 0.93% [1] - Power equipment stocks surged, with Dongfang Electric and Shanghai Electric both rising over 7%, and Northeast Electric increasing by over 5% [1] - Gold stocks saw significant gains, with Zijin Mining rising by over 3% [1] - New consumption concept stocks generally rose, with Cha Bai Dao increasing by over 4% and Guoquan rising by over 3% [1] - Consumer electronics stocks, which were strong yesterday, declined, with most semiconductor stocks experiencing a drop [1] Company News - Hong Kong Technology Exploration (01137.HK) reported a total merchandise transaction value of HKD 636 million in November, a year-on-year decrease of 7.4% [2] - BOE Technology Group (00710.HK) signed a total product processing agreement with BOE in Vietnam [3] - China Galaxy (06881.HK) completed the issuance of a short-term corporate bond worth 4 billion yuan [5] - Cloudy Technology (02670.HK) plans to establish a joint venture focusing on innovative robotic solutions [6] - Nocera Biopharma (09969) received approval for the use of Entrectinib in treating adult and adolescent solid tumors with NTRK fusion genes in China [7] - Peijia Medical-B (09996) received approval from the National Medical Products Administration for the registration application of the TaurusTrio transcatheter aortic valve system [8] - China Antibody-B (03681) had its new drug research application accepted by the National Medical Products Administration [9] - Hengyi Holdings (01894.HK) plans to conduct capital restructuring and fundraising activities [10] Institutional Insights - GF Securities noted that the Hong Kong stock market is more sensitive to external risks, with potential rebound points to watch in mid to late December and early January [11] - Dongwu Securities believes the market is still in a left-side phase and that a rebound requires further waiting [11] - Everbright Securities indicated that while there is significant room for the index to rise compared to previous bull markets, the duration of the bull market may be more important than the magnitude of the increase [11] - Guoxin Securities stated that the recent adjustments in the Hong Kong market could open up space for a market rise in 2026, with over 110 billion yuan of net inflow from southbound funds in November [11] Industry Trends - Ping An Securities highlighted the growing importance of the ice and snow economy, which includes ice and snow sports, tourism, equipment, and culture, as a new economic growth point [12] - The ice and snow industry is experiencing rapid growth, with recommendations to focus on brands with marginal improvements and stable dividend-paying leading companies, specifically mentioning Anta Sports, Bosideng, and Sanfu Outdoor [12]